Identification of a new receptor subtype for tumor necrosis factor-alpha

D M Schwalb1, H M Han, M Marino

  • 1Memorial Sloan-Kettering Cancer Center, New York, New York.

Insights

Researchers discovered a new receptor in human liver that binds tumor necrosis factor-alpha (TNF-alpha) but not TNF-beta. This finding suggests distinct biological roles for these two crucial signaling molecules in normal tissues.

Area of Science:

  • Immunology
  • Cell Biology
  • Molecular Biology

Background:

  • Two known receptors bind both tumor necrosis factor-alpha (TNF-alpha) and tumor necrosis factor-beta (TNF-beta) and have been identified in transformed cells.
  • TNF-alpha and TNF-beta are key cytokines involved in inflammation, immune response, and cell death.

Purpose of the Study:

  • To identify and characterize novel TNF receptor subtypes in normal human tissues.
  • To investigate the binding specificity of TNF receptors in normal human liver plasma membranes (HLPM).

Main Methods:

  • Utilized radioligand binding assays with 125I-TNF-alpha to assess receptor interactions.
  • Employed competition assays using TNF-alpha and TNF-beta to determine binding specificity.
  • Analyzed mRNA expression of known TNF receptors in liver tissue.
  • Used antisera against cloned TNF receptors to probe HLPM.

Main Results:

  • Identified a novel receptor subtype in HLPM that binds TNF-alpha exclusively, not TNF-beta.
  • TNF-alpha, but not TNF-beta, competed for 125I-TNF-alpha binding to HLPM.
  • Antisera to known receptors did not inhibit binding to HLPM, unlike in transformed cell lines.
  • mRNA for both known TNF receptors was present in liver RNA, suggesting post-transcriptional regulation.

Conclusions:

  • Normal human liver expresses a unique TNF receptor with specificity for TNF-alpha.
  • Post-transcriptional modifications likely account for the observed TNF-alpha specificity in HLPM.
  • TNF-alpha and TNF-beta may exert more distinct biological effects on normal tissues than previously understood.

Related Concept Videos

Enzyme-linked Receptors01:00

Enzyme-linked Receptors

Enzyme-linked receptors are proteins that act as both receptor and enzyme, activating multiple intracellular signals. This is a large group of receptors that include the receptor tyrosine kinase (RTK) family. Many growth factors and hormones bind to and activate the RTKs.
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
Receptor Tyrosine Kinases01:26

Receptor Tyrosine Kinases

Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include: